Clinical Trial Update: Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy [Phase 3]

View source ↗

Summary

Phase 3 multicenter randomized trial evaluating 68Ga-PSMA-11 PET/CT-guided salvage radiotherapy after radical prostatectomy for recurrent prostate cancer; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Recurrent Prostate Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING